Galderma Group AG
GALD
Peringkat dalam Saham
#459
Galderma Group AG operates as a dermatology company worldwide. The company... Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, NEMLUVIO, Relfydess, Benzac, and Loceryl in therapeutic dermatology. The company was founded in 1981 and is headquartered in Zug, Switzerland.
Harga Saham
$224.81
Kapitalisasi Pasar
$52.42B
Perubahan (1 hari)
6.31%
Perubahan (1 tahun)
31.28%
Negara
CH
Perdagangan Galderma Group AG (GALD)
Kategori
Healthcare
Riwayat hasil dividen untuk Galderma Group AG (GALD)
Hasil dividen (TTM) dari Galderma Group AG (simbol saham: GALD) per 2024-12-31: 0.00%
Rata-rata hasil dividen selama 5 tahun terakhir: 0.02%
Rata-rata hasil dividen selama 5 tahun terakhir: 0.02%
Riwayat hasil dividen untuk Galderma Group AG (GALD) dari 2021 hingga 2026
Hasil dividen pada akhir setiap tahun (TTM)
| Tahun | Hasil Dividen | Mengubah |
|---|---|---|
| 2026 (TTM) | 0.19% | 137.50% |
| 2025 | 0.08% | 0.00% |
| 2024 | 0.00% | 0.00% |
| 2023 | 0.00% | 0.00% |
| 2022 | 0.00% | 0.00% |
| 2021 | 0.00% | 0.00% |
Hasil dividen (TTM) untuk perusahaan serupa atau pesaing
| Perusahaan | Hasil Dividen | Negara |
|---|---|---|
| 1.63% |
DE
|
|
| 1.50% |
DE
|
|
| 3.18% |
JP
|
|
| 0.91% |
IN
|
|
| 0.43% |
CN
|